Shenyang Kejing showcased its innovative medical hard tissue slicing equipment at the 2025 China Biomaterials Conference.

From October 9th to 12th, 2025, the 2025 China Biomaterials Conference and Exhibition of New Technologies, Products, and Instruments (CSBM 2025) concluded successfully at the Shaoxing International Convention and Exhibition Center in Zhejiang Province. The conference brought together over 3,000 experts, scholars, physicians, and entrepreneurs from domestic and international research institutions, medical institutions, businesses, and regulatory agencies to discuss cutting-edge technologies, innovative products, and future development directions in the fields of biomaterials and medical devices.

One of the highlights of the conference was its robust platform for academic exchange and industry connection. The conference featured six plenary sessions, 162 special reports, and numerous seminars and forums covering a wide range of innovative fields, including bone regeneration biomaterials, nanobiomaterials, reconstructive biomaterials, and brain-computer interface biomaterials. Over 2,800 conference papers were presented, and over 90 renowned companies participated, providing a broad opportunity for interaction between industry experts and researchers.

Shenyang Kejing Automation Equipment Co., Ltd.'s splendid exhibition:

As a leading company in the biomaterials field, Shenyang Kejing Automation Equipment Co., Ltd. showcased its innovative "Complete Medical Hard Tissue Slice Preparation Solution" instrument at the conference. This instrument, boasting unique advanced technology and superior performance, attracted considerable attention from experts and professionals, leading to in-depth discussions.

Kejing's medical hard tissue slice equipment has broad application prospects, particularly in biomaterials research and medical testing. This exhibition not only showcased Kejing's technological strength but also provided more technical support and collaboration opportunities for researchers in the biomaterials field. During the conference, Kejing's technical team engaged in in-depth discussions with experts from around the world on innovative biomaterials technologies and applications, promoting the research and development and application of new materials and technologies.

The Significance of the China Biomaterials Conference:

As one of the most influential academic conferences in the biomaterials field in China, the China Biomaterials Conference not only provides a platform for researchers and companies to showcase their innovative achievements, but also provides a platform for technical exchange and collaboration within the industry. Driven by the new quality productivity policy, biomaterials, as a strategic emerging industry, is experiencing unprecedented development opportunities. The successful conference has injected new momentum into the industry and driven rapid development in the biomaterials field.

Shenyang Kejing's Innovation and Development:

Shenyang Kejing Automation Equipment Co., Ltd. has been dedicated to providing scientific research services to universities, research institutes, scientific research institutions, and small-scale manufacturers for many years. Its products are positioned in the research market, focusing on providing efficient and precise instruments and equipment for laboratories and research institutions. As a dynamic and internationally influential company in the scientific instrument field, Shenyang Kejing consistently upholds the philosophy of "serving society with innovative technology" and is committed to providing customers with high-quality products and advanced services.

The company's core values include pragmatism, dedication, hard work, teamwork, integrity, innovation, and responsibility, and it always adheres to a customer-first service principle. In the future, Shenyang Kejing will continue to leverage its technological advantages to provide one-stop services covering R&D, production, sales, logistics, and after-sales installation. This will promote innovation in the biomaterials field and provide more high-quality products and solutions to the global scientific research and medical industries.